Structural Heart Disease

Structural heart diseases include any issues preventing normal cardiovascular function due to damage or alteration to the anatomical components of the heart. This is caused by aging, advanced atherosclerosis, calcification, tissue degeneration, congenital heart defects and heart failure. The most commonly treated areas are the heart valves, in particular the mitral and aortic valves. These can be replaced through open heart surgery or using cath lab-based transcatheter valves or repairs to eliminate regurgitation due to faulty valve leaflets. This includes transcatheter aortic valve replacement (TAVR). Other common procedures include left atrial appendage (LAA) occlusion and closing congenital holes in the heart, such as PFO and ASD. A growing area includes transcatheter mitral repair or replacement and transcatheter tricuspid valve repair and replacement.

RSS icon
Thumbnail

STEMI patients with aortic stenosis face an increased risk of death

Aortic stenosis is only seen in 1% of younger STEMI patients, but it becomes more and more common as patients get older. 

Thumbnail

Florida hospital celebrates 100th TAVR procedure

The procedure, like the hospital's first 99 TAVR cases, was a success. 

Thumbnail

Valve-in-valve TAVR outcomes ‘excellent’ after one year

Moderate to severe aortic regurgitation was seen in 0.9% of patients after 30 days and 1.3% after one year.

Tai chi could help ease depression, anxiety among stroke survivors

An eight-week tai chi course provided key benefits for older stroke survivors, researchers reported. 

How predilation affects TAVR outcomes for low-risk patients

The new study, published in Circulation: Cardiovascular Interventions, included data from nearly 500 TAVR patients.

Thumbnail

TEER with MitraClip XTR leads to consistent TR reduction, outperforming older devices

Researchers reported a technical success rate of 100%, but they did urge caution if the patient's coaptation gap size exceeds 8.4 mm. 

Thumbnail

To delay or not to delay? When treating TAVR patients during the pandemic, heart teams faced big decisions

Delaying TAVR for six months can have a negative effect on patient outcomes. During the pandemic, however, there were certain times when a delay was safer than completing the procedure. 

Thumbnail

Thanks to newer heart valves, aortic angulation no longer affects TAVR outcomes

With older heart valves, a higher degree of aortic angulation was often associated with post-TAVR complications. 

Displaying 593 - 600 of 879
Design by Adaptive Theme